Postmenopausal women with high levels of high-density lipoproteins (HDL) did not have the same cardioprotective benefits typically seen in women of other ages, researchers reported in the American Heart Association journal Arteriosclerosis, Thrombosis and Vascular Biology.

Intensive blood pressure lowering helped reduce the risk of mild cognitive impairment (MCI), according to a substudy from the SPRINT trial presented last week at the Alzheimer’s Association International Conference in Chicago.

A recent review of almost 80 randomized control trials suggests increased intake of long-chain omega-3 (LCn3) polyunsaturated fatty acids from oily fish have minimal to no effect on mortality or cardiovascular health. Results of the review were published online July 18 in the Cochrane Library.

A hypertension management protocol from an integrated healthcare system was successfully adopted by a network of safety-net clinics, resulting in substantial improvements in blood pressure control for patients of all races.

The FDA on Friday, July 13, joined more than 20 other countries in recalling medications containing valsartan, an active ingredient used to treat hypertension and heart failure. Some of the medications with valsartan have been contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen.

The average blood pressure of American youths is declining, a new CDC report suggests, even as updated guidelines classify almost 800,000 more of them as hypertensive.

A tuberculosis vaccine that has been around for a century is being investigated as a potential low-cost, long-term treatment for type 1 diabetes.

Adoption of the new 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines would result in a “substantial” increase in the prevalence of hypertension in both the U.S. and China.